FreeOx receives recognition from EIT Health

FreeOx Biotech has been selected for two first level programmes of EIT Health, a network of more than 140 member universities and companies which innovate in healthcare supported by the European Institute of Innovation and Technology (EIT) of the European Commission....

Innovative solution against the dreaded stroke

In an interview published in the Catalan newspaper "La vanguardia", Carlos Lurigados and Ángel Chamorro, CEO and Scientific Advisor of FreeOx Biotech respectively, talk about the creation of the company in 2007 as a spinout of the Hospital Clínic, of the recent...

FreeOx opens €500,000 round of investment

FreeOx Biotech has opened a round of investment hoping to raise €500,000 by June. The company’s goal this year is to accelerate development and the regulatory process for its drug candidate Ox-01, which has completed phase IIb, and begin preclinical trials with Ox-02....

Este médico es la esperanza contra el ictus

El neurólogo Ángel Chamorro ha descubierto una fórmula que aumenta las probabilidades de salir indemne del ictus. Lo ha experimentado en el Hospital Clínic de Barcelona. Y funciona. Con su descubrimiento se podrían curar del todo 36.000 españoles al año. Nos lo...